NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluation of Pain Treatment After Total Knee Arthroplasty

NCT07538570

RecruitingPhase 4

Sponsor: Vertex Pharmaceuticals Incorporated

Conditions: Pain

Interventions: Suzetrigine, Placebo

Countries: United States

The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).

Eligibility overview

Sex: ALL

Age: 18 Years to 80 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Key Inclusion Criteria:

* Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2)
* Scheduled to undergo an elective primary unilateral TKA surgery

Key Exclusion Criteria:

\- History of previous TKA surgery on incident side

Other protocol defined Inclusion/Exclusion criteria will apply.

Locations (2)

Bellaire, Texas, United States
Houston, Texas, United States